Results

Total Results: 543 records

Showing results for "anticoagulant prophylaxis".

  1. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
    May 01, 2010 - Pediatric cardiac surgery A total of 40 patients received rFVIIa prophylaxis in one poor quality RCT
  2. Paul Tedrick (doc file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/archived-webinars/mindfulness-transcript.doc
    June 10, 2014 - We need intensivists to be engaged in our ICUs and surgeons to help us with improving surgical prophylaxis
  3. www.ahrq.gov/hai/cauti-tools/archived-webinars/mindfulness-transcript.html
    December 01, 2017 - We need intensivists to be engaged in our ICUs and surgeons to help us with improving surgical prophylaxis
  4. Paul Tedrick (doc file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/archived-webinars/mindfulness-transcript.doc
    June 10, 2014 - We need intensivists to be engaged in our ICUs and surgeons to help us with improving surgical prophylaxis
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
    January 01, 2002 - At that time, the Task Force found insufficient evidence to recommend for or against routine aspirin prophylaxis … Concomitant use of other nonsteroidal anti-inflammatory agents or anticoagulants further increased risk … Aspirin for the Primary Prevention of Cardiovascular Events 24 Adults without known CVD Aspirin prophylaxis
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
    April 01, 2012 - concomitant prescription drugs from, on average, 5.9 different drug classes for primary and secondary prophylaxis … : 40-55 years Mixed gender Unclear CHD risk 6-25 weeks treatment INR Vitamin K (150 μg /day) + Anticoagulants … combination with antiplatelet agents (acetylsalicylic acid,65,66 clopidogrel,67 or ticlopidine68), an anticoagulant … Overall evidence indicates that supplementation with vitamin K may improve the stability of anticoagulant … or withdrawal due to adverse events.41 This study recruited 70 participants with indications for anticoagulant
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
    April 01, 2012 - concomitant prescription drugs from, on average, 5.9 different drug classes for primary and secondary prophylaxis … : 40-55 years Mixed gender Unclear CHD risk 6-25 weeks treatment INR Vitamin K (150 μg /day) + Anticoagulants … combination with antiplatelet agents (acetylsalicylic acid,65,66 clopidogrel,67 or ticlopidine68), an anticoagulant … Overall evidence indicates that supplementation with vitamin K may improve the stability of anticoagulant … or withdrawal due to adverse events.41 This study recruited 70 participants with indications for anticoagulant
  8. digital.ahrq.gov/sites/default/files/docs/citation/r01hs026732-usher-final-report-2023.pdf
    January 01, 2023 - ; 95% CI, 0.66-0.99) and the use of COVID-19–specific therapeutics including deep vein thrombosis prophylaxis
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
    June 01, 2010 - However, we more clearly identify where on the continuum of prophylaxis-treatment-end-stage these studies … While some studies might hint towards an early intervention (e.g., in prophylaxis use) in high-risk
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
    June 01, 2010 - However, we more clearly identify where on the continuum of prophylaxis-treatment-end-stage these studies … While some studies might hint towards an early intervention (e.g., in prophylaxis use) in high-risk
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/data-extraction-google_research.pdf
    January 01, 2013 - Cardiac function Colorectal cancer Diabetes mellitus education Diabetes mellitus prevention Fungal prophylaxis … [Comparison of micafungin and fosfluconazole as prophylaxis for invasive fungal infection during neutropenia … Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT
  12. ce.effectivehealthcare.ahrq.gov/hai/cauti-tools/archived-webinars/mindfulness-transcript.html
    December 01, 2017 - We need intensivists to be engaged in our ICUs and surgeons to help us with improving surgical prophylaxis
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - estimated 2.7 million to 6.1 million patients who currently have AF have one or more contraindications to anticoagulants … About half of the patients with contraindications to anticoagulants (550,000 to 1.2 million) are at … expected to be diagnosed each year, and if 40% (64,000) of these new cases have contraindications to anticoagulants … Centers for Disease Control and Prevention (CDC) recommends pre-exposure prophylaxis (PrEP) for males
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - estimated 2.7 million to 6.1 million patients who currently have AF have one or more contraindications to anticoagulants … About half of the patients with contraindications to anticoagulants (550,000 to 1.2 million) are at … expected to be diagnosed each year, and if 40% (64,000) of these new cases have contraindications to anticoagulants … Centers for Disease Control and Prevention (CDC) recommends pre-exposure prophylaxis (PrEP) for males
  15. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer
    April 11, 2016 - Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular
  16. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular
  17. CERs Report cover (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
    September 01, 2010 - of strategies to optimize benefits and minimize harms, such as the concurrent use of a SERM and an anticoagulant … Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence … Future trials could evaluate the benefits and harms of using tamoxifen or raloxifene with an anticoagulant
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - of strategies to optimize benefits and minimize harms, such as the concurrent use of a SERM and an anticoagulant … Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of … Future trials could evaluate the benefits and harms of using tamoxifen or raloxifene with an anticoagulant
  19. CERs Report cover (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
    September 01, 2010 - of strategies to optimize benefits and minimize harms, such as the concurrent use of a SERM and an anticoagulant … Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence … Future trials could evaluate the benefits and harms of using tamoxifen or raloxifene with an anticoagulant
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - of strategies to optimize benefits and minimize harms, such as the concurrent use of a SERM and an anticoagulant … Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of … Future trials could evaluate the benefits and harms of using tamoxifen or raloxifene with an anticoagulant